These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 17607161)

  • 1. Effects of selective iNOS inhibition on systemic hemodynamics and mortality rate on endotoxic shock in streptozotocin-induced diabetic rats.
    Kadoi Y; Goto F
    Shock; 2007 Nov; 28(5):602-9. PubMed ID: 17607161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the cannabinoid antagonist AM281 on systemic hemodynamics and mortality rate in streptozotocin-induced diabetic rats with endotoxic shock: comparison between non-diabetic and diabetic rats.
    Kadoi Y; Hinohara H; Kunimoto F; Saito S
    Acta Anaesthesiol Scand; 2008 May; 52(5):664-72. PubMed ID: 18261198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
    Ghaznavi R; Kadkhodaee M
    Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
    Nagareddy PR; McNeill JH; MacLeod KM
    Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
    Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
    Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia.
    Robinson EK; Seaworth CM; Suliburk JW; Adams SD; Kao LS; Mercer DW
    Shock; 2006 May; 25(5):507-14. PubMed ID: 16680016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally-induced septic shock in rats.
    Kadoi Y; Goto F
    Anesth Analg; 2004 Jul; 99(1):212-220. PubMed ID: 15281532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition.
    Zhang C; Walker LM; Hinson JA; Mayeux PR
    J Pharmacol Exp Ther; 2000 Jun; 293(3):968-72. PubMed ID: 10869399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D; Schwartz IF; Blantz RC
    J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation.
    Strunk V; Hahnenkamp K; Schneuing M; Fischer LG; Rich GF
    Anesth Analg; 2001 Mar; 92(3):681-7. PubMed ID: 11226101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Badn W; Hegardt P; Fellert MA; Darabi A; Esbjörnsson M; Smith KE; Janelidze S; Salford LG; Visse E; Siesjö P
    Scand J Immunol; 2007 Mar; 65(3):289-97. PubMed ID: 17309784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral neural aspects of gastroprotective and ulcer healing effects of lipopolysaccharides.
    Konturek PC; Brzozowski T; Meixner H; Ptak A; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):611-23. PubMed ID: 11787762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-lysine on nitric oxide overproduction in endotoxic shock.
    Liaudet L; Gnaegi A; Rosselet A; Markert M; Boulat O; Perret C; Feihl F
    Br J Pharmacol; 1997 Oct; 122(4):742-8. PubMed ID: 9375972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide produced by constitutive and inducible nitric oxide synthases in the mouse gastric fundus.
    Arab HA; Hassanpour H; Bozorgi A
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1038-42. PubMed ID: 18505451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-NAME and L-Arg on arterial blood pressure in normotensive and hypertensive streptozotocin diabetic rats.
    Costa MA; Balaszczuk AM; Domínguez A; Catanzaro O; Arranz C
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):59-63. PubMed ID: 9695876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of inducible nitric oxide synthase reduces lipopolysaccharide-induced renal injury in the rat.
    Kadkhodaee M; Qasemi A
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):842-6. PubMed ID: 15659046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
    Pullamsetti SS; Maring D; Ghofrani HA; Mayer K; Weissmann N; Rosengarten B; Lehner M; Schudt C; Boer R; Grimminger F; Seeger W; Schermuly RT
    Thromb Haemost; 2006 Apr; 95(4):720-7. PubMed ID: 16601845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice.
    Wu L; Mayeux PR
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1061-7. PubMed ID: 17202403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.